Five Prime Therapeutics prices IPO at $13, within the range

By
A A A

Five Prime Therapeutics, which is developing protein therapeutics for cancers and autoimmune diseases, raised $62 million by offering 4.8 million shares at $13, within the range of $12 to $14. Five Prime Therapeutics plans to list on the NASDAQ under the symbol FPRX. Five Prime Therapeutics initially filed confidentially on 6/14/2013. Jefferies, BMO Capital Markets and Wells Fargo Securities acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: FPRX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

113,590,482
  • $14.98 ▼ 1.77%
57,689,941
  • $94.67 ▼ 0.37%
51,501,990
  • $3.31 ▼ 2.07%
46,645,770
  • $96.13 ▲ 0.55%
42,212,567
  • $72.36 ▼ 0.40%
39,428,076
  • $25.35 ▲ 0.80%
36,799,747
    $37 unch
36,459,390
  • $44.13 ▼ 2.35%
As of 8/1/2014, 04:03 PM